ALENDRONATE 70 THERAPY IN ELDERLY WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: THE PROBLEM OF COMPLIANCE

被引：0
|
作者：
Sewerynek, Ewa [1 ,2 ]
Stuss, Michal [1 ,2 ]
Malkowski, Bogdan [3 ]
Karzewnik, Ewa [2 ,4 ]
Stepien-Klos, Wioletta [2 ]
Tabaszewska, Maria
Lasota, Marek [5 ]
Krupinska, Grazyna
Gladalska, Anna
Horst-Sikorska, Wanda [6 ]
机构：
[1] Med Univ Lodz, Dept Endocrine Disorders & Bone Metab, Lodz, Poland
[2] Vet Cent Hosp, Outpatient Clin Osteoporosis, Mil Teaching Hosp, Lodz, Poland
[3] Inst Oncol, Bydgoszcz, Poland
[4] Outpatient Clin Endocrinol Piotrkow Trybunalski, Piotrkow Trybunalski, Poland
[5] Jonschers Hosp, Clin Orthopaed, Lodz, Poland
[6] Med Univ Poznan, Dept Family Med, Poznan, Poland
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [1] Alendronate 70 therapy in elderly women with post-menopausal osteoporosis: the problem of compliance
    Sewerynek, Ewa
    Malkowski, Bogdan
    Karzewnik, Ewa
    Stepien-Klos, Wioletta
    Tabaszewska, Maria
    Lasota, Marek
    Krupinska, Grazyna
    Gladalska, Anna
    Horst-Sikorska, Wanda
    Stuss, Michal
    [J]. ENDOKRYNOLOGIA POLSKA, 2011, 62 (01) : 24 - 29
  • [2] Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis
    Sewerynek, Ewa
    Dabrowska, Katarzyna
    Skowronska-Jozwiak, Elibieta
    Zygmunt, Arkadiusz
    Lewinski, Andrzej
    [J]. ENDOKRYNOLOGIA POLSKA, 2009, 60 (02) : 76 - 81
  • [3] Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
    Radwan, Asma
    Shraim, Naser
    Elaraj, Josephean
    Hamad, Anwar
    Fatayer, Dana
    Jarar, Bayan
    Johar, Ayoub
    Zriqah, Areen
    [J]. BMC WOMENS HEALTH, 2022, 22 (01)
  • [4] Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
    Asma Radwan
    Naser Shraim
    Josephean Elaraj
    Anwar Hamad
    Dana Fatayer
    Bayan Jarar
    Ayoub Johar
    Areen Zriqah
    [J]. BMC Women's Health, 22
  • [5] Satisfaction, preference and compliance with alendronate and risedronate in postmenopausal women with osteoporosis
    Pérez, LI
    Sanidefonso, MM
    Paleo, EE
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S42 - S42
  • [6] The effectiveness of alendronate (70 mg weekly) in women with postmenopausal osteoporosis
    Martchenkova, L. A.
    Dreval, A. V.
    Kryukova, I. V.
    Tishenina, R. S.
    Milov, N. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S44 - S44
  • [7] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [8] Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
    You, Ruxu
    Liu, Zijie
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] THE ROLE OF COUNSELLING AND OTHER FACTORS IN COMPLIANCE OF POSTMENOPAUSAL OSTEOPOROSIS PATIENTS TREATED WITH ALENDRONATE 70
    Sewerynek, Ewa J.
    Horst-Sikorska, Wanda
    Stepien-Klos, Wioletta
    Antkowiak, Agnieszka
    Janik, Malgorzata
    Cieslak, Karol
    Marcinkowska, Michalina
    Stuss, Michal
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S94 - S94
  • [10] COMPARISON OF PREFERENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS BETWEEN THERAPY WITH DENOSUMAB AND/OR ALENDRONATE
    Solakov, Panayot
    Kuzmanova, Stefka
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S274 - S274
12345